Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Uni-Bio Science Group Limited Audit Report / Information 2013

Sep 4, 2013

49397_rns_2013-09-04_d0709310-1b52-409c-85cc-4ec2c40ef786.pdf

Audit Report / Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [316 x 59] intentionally omitted <==

(incorporated in the Cayman Islands with limited liability)

(stock code: 690)

ANNOUNCEMENT

The Board of the Company is pleased to inform the shareholders that all the field-work in respect of the follow-up review performed by the independent internal control adviser has been completed. The Company has put in place and taken corresponding remedial actions to address the previous comments of the internal control adviser noted in their first round review. The final report is expected to be issued within the next few weeks after final discussion and approval by the Board.

Reference is made to the Company’s announcement dated 28 March 2013. Unless otherwise specified, terms used herein shall have the same meaning as those defined in the announcement.

The Board of Directors (the “ Board ”) of the Company is pleased to inform the shareholders that all the field-work in respect of the second round review (the “ follow-up review ”) performed by the independent internal control adviser has been completed. The Company has put in place and taken corresponding remedial actions to address the previous comments of the internal control adviser noted in their first round review. The final report is expected to be issued within the next few weeks after final discussion and approval by the Board.

  • For identification purpose only

– 1 –

The Audit Committee believes that after the implementation of the said mitigation measures, there exists adequate internal control system within the Group.

By order of the Board Uni-Bio Science Group Limited TONG Kit Shing

Chairman

Hong Kong, 4 September 2013

As at the date of this announcement, the executive directors of the Company are Mr. TONG Kit Shing (Chairman), Mr. LIU Guoyao and Mr. LEUNG Ka Chun; the independent non-executive directors of the Company are Mr. TSAO Hoi Ho, Terry, Mr. LOU Iok Kuong, Mr. NG Pak Kin and Mr. LEUNG Wai Chung, Vincent.

– 2 –